Open report — full analysis, no account required.
Sign up to generate reports and read filings that aren't on the open list.
Get notified when ZBH files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsZimmer Biomet reports Q1 2026 earnings results
Filed April 28, 2026 · Period ending April 28, 2026 · ~1 min read
Key Changes
-
high
Zimmer Biomet issued a press release disclosing financial results for the quarter ended March 31, 2026. Specific revenue, earnings, and guidance metrics are contained in the attached press release.
Item 2.02 verify on EDGAR →
Summary
Zimmer Biomet filed an 8-K on April 28, 2026 to announce its first quarter 2026 financial results. This is a standard quarterly earnings disclosure required by SEC rules. The filing itself is procedural—the actual financial performance data, including revenue, earnings per share, segment results, and any forward guidance, are contained in the attached press release (Exhibit 99.1), which was not included in the filing text provided.
For retail investors, this represents routine quarterly reporting. The key information to review would be the full press release and any accompanying earnings call transcript to understand how the company performed against expectations and what management's outlook is for the remainder of 2026. Watch for analyst commentary and any guidance updates in the coming days to gauge market reaction to the quarter's results.
Section-by-Section Diff
Event · Item 2.02 — Results of Operations and Financial Condition
Item 2.02 — Results of Operations and Financial Condition filed; see Key Changes for terms.
Added in current filing · verify on EDGAR →
On April 28, 2026, Zimmer Biomet Holdings, Inc. (the “Company”) issued a press release reporting its financial results for the quarter ended March 31, 2026.
The company disclosed its first quarter 2026 financial results through a press release. The actual financial metrics and performance details are contained in the attached press release exhibit, which is incorporated by reference into this 8-K filing.
Event · Item 9.01 — Financial Statements and Exhibits
Zimmer Biomet filed an 8-K attaching a press release dated April 28, 2026; no material business event disclosed in the filing body.
Show 1 minor / wording change
Added in current filing · verify on EDGAR →
Press release dated April 28, 2026
The 8-K references an attached press release dated April 28, 2026 (Exhibit 99.1). The filing body itself contains no substantive disclosure about the press release content, making this a procedural filing. The actual material information would be in the press release exhibit, which is not included in the provided text.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Jun 2, 2026 · How we verify